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Young adulthood represents a significant phase in the development of addiction, as the transition 
from occasional, experimental users of tobacco and cannabis into dependent problematic use of 
both may occur during this period. Usage patterns of tobacco, nicotine and cannabis products are 
shifting constantly against the backdrop of evolving product ranges and increasing legalisation of 
cannabis, and the research community needs to keep pace in order to develop relevant and effective 
prevention and treatment interventions for this age group.  
Popova et al [1] provide a comprehensive and thought-provoking analysis of perceptions of tobacco, 
cannabis and electronic vaporisers. Their paper investigates the perceived relative harms of each 
and provides a framework of how young adults conceptualise these. However, it does not 
investigate the perceived combined impact of using tobacco and cannabis concurrently (i.e. co-use 
of cigarettes and cannabis) or simultaneously (i.e. co-administered within the same product). 
The most common route of cannabis consumption across Europe and in some parts of the world is 
with tobacco; that is co-administered in a single product. In the United States it is smoked more 
commonly without tobacco, but co-use (i.e. use of both products but not simultaneously) is 
increasing across all age groups [2-4]. Popova et al [1] do not detail usage patterns of their 
interviewees, but evidence suggests that many US young adults do co-use [3].  
 
Research investigating the bi-directional impacts of marijuana and tobacco is gaining traction. For 
example, both ‘gateway’ and ‘reverse gateway’ effects that can lead to the development of 
dependency and/or problematic use have been demonstrated [5-7]. Both substances, used 
simultaneously, can impact cognition [8] and co-use leads to poorer psychosocial, cessation, and 
health outcomes [9,10]..Indeed the most significant and consistent positive association shown for 
co-use is exacerbation of mental health symptoms [11]. Nevertheless, the psychological and physical 
impact that each substance has on the other, and on the user, still requires further investigation. 
This seems crucial, given the high rates of young adult use among both European and world-wide co-
users. In light of the current socio-political environment surrounding cannabis, the subsequent effect 
on tobacco use and cessation requires monitoring in longitudinal population surveys.  
 
The qualitative evidence presented by Popova et al [1] suggests that young adults may use one 
product to quit another. Whilst evidence on the impact of co-use is provided by a number of survey 
studies [3, 4, 12, 13], we still know very little about users’ perspectives on interchanging products, 
whether or not this occurs consciously, and what are the perceived outcomes for users.  
 
To prevent young adults developing problematic use of either substance, we need to investigate 
what significant factors relate to co-use, and what motivates co-use and quit attempts. The natural 
history of co-use, cessation and the potential for the substitution effect of cannabis and tobacco [14] 
also requires exploration particularly from their perspective of the user [3,4,12]. Additionally, we 
need to know which quit methods are practised and appear feasible and effective, whether dual quit 
attempts are simultaneous or sequential and what role other products such as e-cigarettes (and 
cannabis vaporisers [15]) might play.  To develop effective interventions, we also need to test 
whether existing theoretical frameworks such as the Behaviour Change Wheel [16] are relevant for 
characterising co-use and assisting dual quit attempts.  
 
 
The close relationship between tobacco and cannabis operates across multiple domains, including 
cultural and psychosocial, in addition to biochemical and clinical interactions. The complexity of this 
unique relationship is enhanced by the frequent shared route of administration, and we propose 
that this relationship require investigation. Tobacco and cannabis must be considered hand in hand, 
as the impact and harms and of both may be greater than the sum of their parts.  
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